Exemestane 25mg
| Product Overview | |
| Generic Name | Exemestane 25mg |
| Brand Name(s) | AROMASIN®, Nodutax, Xenq, Zurimacin |
| Form | 30 Oral tablet |
| Strength | 25 mg |
| Therapeutic Class | Aromatase inhibitor |
| ATC Code | L02BG06 |
| Manufacturing & Regulatory | |
| Manufacturer | Pfizer, Sun Pharmaceutical Ltd |
| Country | USA, India, EU |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.5418.02 |
| Free Sale Certificate | Available per batch upon request |
| Logistics & Export | |
| MOQ | 10 Units |
| Shelf Life | 36 months |
| Storage | Store = 25 °C, protect from light |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
Description
Exemestane is an aromatase inhibitor used for hormone-receptor-positive breast cancer in postmenopausal women, including (i) adjuvant treatment after 2–3 years of tamoxifen to complete 5 years of endocrine therapy, and (ii) advanced breast cancer progressing after tamoxifen. Standard dose in labeling is 25 mg once daily after a meal
